Chester County News and Community Website
RADNOR, PA — In a significant development that could revolutionize the treatment of complicated urinary tract infections (cUTI) and pyelonephritis, NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has received Qualified Infectious Disease …
NRx Pharmaceuticals’ NRX-101 Receives FDA Fast Track Designation: A Potential Gamechanger for Treating Complex UTIs Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced this week that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designations to its investigational therapy, CABA-201.
Cabaletta Bio Fast-Tracks Potential Autoimmune Breakthrough Read More
The U.S. Food and Drug Administration (FDA) recently authorized Florida’s Agency for Health Care Administration to import certain prescription drugs from Canada under section 804 of the Federal Food, Drug, …
Florida Gets Green Light from FDA to Import Prescription Drugs from Canada: A Potential Game-Changer for U.S. Healthcare Costs Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that it received the minutes from its recent Type C meeting with the U.S. Food and Drug Administration (FDA). …
Verrica Pharmaceuticals Gains FDA Alignment for YCANTH’s Phase 3 Clinical Development Plan Read More RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced the clearance of its Investigational New Drug Application (IND) by the US Food and Drug Administration …
NRx Pharmaceuticals Secures FDA Clearance for Novel UTI Treatment, Plans Spin-Off Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company, recently announced that it has received alignment from the U.S. Food and Drug Administration (FDA) on the design of a …
Ocugen Gains FDA Alignment for Phase 3 Trial of Retinitis Pigmentosa Treatment Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a Pennsylvania-based biopharmaceutical company, has scored a significant regulatory milestone this week with the U.S. Food and Drug Administration (FDA) granting Regenerative Medicine …
Ocugen’s OCU400 Earns FDA’s RMAT Designation, Enhancing Prospects for Retinitis Pigmentosa Treatment Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of its NeuroSite™ Coil Placement Accessory. The state-of-the-art tool, designed to …
Neuronetics Secures FDA Clearance for NeuroSite, Streamlining Mental Health Treatments Read More
EXTON, PA — In a move that strengthens its position as a global leader in innovative solutions for injectable drug administration systems, West Pharmaceutical Services, Inc. (NYSE: WST) recently announced …
West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company specializing in innovative solutions for mental health, has announced that its NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy System …
Neuronetics’ NeuroStar TMS Therapy System Receives Advanced Approval in Japan, Paving the Way for Enhanced Depression Treatment Read More